Precigen (PGEN)
(Delayed Data from NSDQ)
$1.45 USD
+0.05 (3.57%)
Updated Mar 27, 2024 04:00 PM ET
After-Market: $1.45 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth F Momentum F VGM
Income Statements
Fiscal Year end for Precigen, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 6 | 27 | 104 | 103 | 91 |
Cost Of Goods | 6 | 6 | 58 | 56 | 61 |
Gross Profit | 0 | 21 | 45 | 48 | 29 |
Selling & Adminstrative & Depr. & Amort Expenses | 100 | 96 | 125 | 134 | 234 |
Income After Depreciation & Amortization | -100 | -76 | -79 | -87 | -204 |
Non-Operating Income | 4 | 3 | 1 | 1 | 13 |
Interest Expense | 0 | 7 | 19 | 18 | 18 |
Pretax Income | -96 | -80 | -97 | -104 | -209 |
Income Taxes | 0 | 0 | 0 | 0 | -1 |
Minority Interest | 0 | 0 | 0 | 0 | -2 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -96 | -80 | -97 | -104 | -208 |
Extras & Discontinued Operations | 0 | 108 | 5 | -67 | -116 |
Net Income (GAAP) | -96 | 28 | -92 | -171 | -322 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -84 | -63 | -53 | -49 | -179 |
Depreciation & Amortization (Cash Flow) | 15 | 13 | 27 | 37 | 26 |
Income After Depreciation & Amortization | -100 | -76 | -79 | -87 | -204 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 244.54 | 200.36 | 197.76 | 167.07 | 154.14 |
Diluted EPS Before Non-Recurring Items | -0.35 | -0.40 | -0.49 | -0.35 | -0.88 |
Diluted Net EPS (GAAP) | -0.39 | 0.14 | -0.47 | -1.02 | -2.09 |
Fiscal Year end for Precigen, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | 12/31/22 | |
---|---|---|---|---|---|
Sales | 1.23 | 1.38 | 1.77 | 1.85 | -24.75 |
Cost Of Goods | 1.36 | 1.54 | 1.70 | 1.53 | -14.15 |
Gross Profit | -0.13 | -0.16 | 0.07 | 0.32 | -10.60 |
SG&A, R&D, and Dept/Amort Expenses | 33.64 | 20.78 | 21.19 | 23.80 | 15.45 |
Income After SG&A, R&D, and Dept/Amort Expenses | -33.77 | -20.94 | -21.12 | -23.48 | -26.05 |
Non-Operating Income | 0.84 | 1.14 | 0.87 | 1.01 | -0.15 |
Interest Expense | 0.01 | 0.00 | 0.14 | 0.32 | 0.61 |
Pretax Income | -33.39 | -19.80 | -20.38 | -22.79 | -26.82 |
Income Taxes | -0.33 | -0.01 | -0.07 | -0.06 | 0.01 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -33.06 | -19.80 | -20.32 | -22.73 | -26.82 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 4.65 |
Net Income (GAAP) | -33.06 | -19.80 | -20.32 | -22.73 | -22.18 |
Earnings Per Share Data | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | 12/31/22 |
---|---|---|---|---|---|
Average Shares | 254.28 | 248.52 | 248.00 | 229.77 | NA |
Diluted EPS Before Non-Recurring Items | -0.09 | -0.08 | -0.08 | -0.10 | NA |
Diluted Net EPS (GAAP) | -0.13 | -0.08 | -0.08 | -0.10 | -0.11 |